TrimRx's Blog

8 min read

AHK-Cu Dosing Protocol: Cycling, Frequency & Best Practices

AHK-Cu is dosed differently from most peptides people research, because it is used topically rather than injected.

14 min read

AHK-Cu Complete Guide: Benefits, Dosing, Side Effects & Research

AHK-Cu is a copper peptide used in topical products to support hair growth and skin health.

9 min read

ACA Marketplace Plans and GLP-1: 2027 Open Enrollment Guide

Introduction ACA marketplace plans cover GLP-1 drugs inconsistently, so the 2027 open enrollment is your chance to compare formularies and pick a plan that…

9 min read

A1C 5.7 to 6.4: Your GLP-1 Decision Framework

An A1C between 5.7% and 6.4% puts you in prediabetes, and the right move depends on where in that band you sit plus your other risk factors.

12 min read

The 6-Month Maintenance Checkpoint: Audit Your Systems

Six months after reaching your goal weight is exactly when you should sit down and audit every system that got you there.

10 min read

503A Peptide Pharmacies Explained: Why Sourcing Matters

Introduction A 503A pharmacy is a state-licensed compounding pharmacy that makes a medication for one specific patient based on a prescription, following USP quality…

10 min read

The 5-Year View: Long-Term GLP-1 Users Tell the Truth

Five years into GLP-1 treatment, the people doing well share one belief: this is chronic disease management, not a diet with an end date.

9 min read

5-Amino-1MQ vs MOTS-c: NNMT vs Mitochondrial Signaling

Introduction 5-Amino-1MQ and MOTS-c both get pitched for metabolism and body composition, but they work through different mechanisms, and that is the substance of…

8 min read

Stacking 5-Amino-1MQ with GLP-1: What to Know Before Combining

There is no published evidence on stacking 5-Amino-1MQ with a GLP-1 medication, so any confident protocol is invented.

Stay on Track

Join our community and receive:
Expert tips on maximizing your GLP-1 treatment.
Exclusive discounts on your next order.
Updates on the latest weight-loss breakthroughs.